News Becton, Dickinson and Company Deutsche Boerse AG

Stocks

BOX

US0758871091

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 11:25:43 2026-09-07 EDT			5-day change	1st Jan Change
157.42 ^EUR	-1.92%		-3.05%	-4.86%

09-01	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat	MT
08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT

All News

Mentions Relevance

08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
08-27	Becton Dickinson Reaches 50% Enrollment in Breast Surgery Trial	MT
08-27	BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation	PR
08-26	BD to Present at Wells Fargo 21st Annual Healthcare Conference	PR
08-17	Becton, Dickinson and Company Announces Management Changes	CI
08-17	Becton Dickinson Names Gary Sorsher as Chief Quality Officer	MT
08-17	BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire	PR
08-17	Jeffrey Silvestri to Retire as Senior Vice President, Global Head of Quality of Becton, Dickinson and Company in October 2026	CI
08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-12	Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh	MT
08-12	BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial	PR
08-12	Becton, Dickinson And Company Completes Enrollment In The PREVENT Clinical Trial Evaluating Phasix Mesh For Incisional Hernia Prevention	CI
08-07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-06	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 28, 2025.	CI
08-06	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026.	CI